http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RO-98727-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c69978471d06e61e6562700cc0b24102
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3469e88c0da67577f19944a61e22c094
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-21
filingDate 1987-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1738bc63a346eee08974ecd66f105bb3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bc0462c3effea9048840dc92310499a
publicationDate 1990-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RO-98727-B1
titleOfInvention MEDICINE USED IN TREATMENT OF GASTRIC AND DUODENAL ULTRAS
abstract The present invention relates to a drug used in the treatment of gastric and duodenal ulcers, which, in order to correct vascular perturbations involved in ulcerogenesis, consists of 1.6% nitroglycerin solution 1%, 0.8% procaine hydrochloride, 2% papaverine hydrochloride, 6% magnesium trisilicate, 6% 2% carboximethylcellulose mucilage, 8% beladon syrup, 28% mint water and up to 100% preservative solution.
priorityDate 1987-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449288622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4510
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505263
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555446
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448783041

Total number of triples: 23.